Savvy Updates, 1/20/20:

Savvy Updates, 1/20/20:

Eli Lilly Unveils Another Round of Lower-Cost Insulin Products was reported by Alex Keown bor BioSpace.com, 15 January 2020.  Eli Lilly is adding additional reduced cost insulin options to patients. The Indianapolis-based company announced lower-priced versions...
Savvy Updates, 12/16/19:  FDA Approves Tandem Control-IQ, On Dexcom’s Outage, Pacific Diabetes Tech CGM/Infusion Set, Sanofi Exits Diabetes Biz, CGMs 2020, T1 Females at Higher Heart Risk, Abbott Libre Limits Data Access, Gifts for Medical Professionals?

Savvy Updates, 12/16/19: FDA Approves Tandem Control-IQ, On Dexcom’s Outage, Pacific Diabetes Tech CGM/Infusion Set, Sanofi Exits Diabetes Biz, CGMs 2020, T1 Females at Higher Heart Risk, Abbott Libre Limits Data Access, Gifts for Medical Professionals?

FDA OKs Tandem Diabetes Control-IQ! was reported by Mike Hoskins for DiabetesMine.com, 13 December 2019.  Control-IQ combines Tandem’s touchscreen insulin pump with the popular Dexcom CGM (continuous glucose monitor) and a smart algorithm that not only...